Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro
- PMID: 2158278
- PMCID: PMC171593
- DOI: 10.1128/AAC.34.2.373
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro
Abstract
Ganciclovir and foscarnet possess substantial activity against cytomegalovirus. Both exhibit dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic inhibition of cytomegalovirus replication in vitro by ganciclovir and foscarnet. Reduced-dose combination therapy may provide a means to treat patients with cytomegalovirus infection while reducing drug toxicity.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
